Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-003817
Filing Date
2025-06-04
Accepted
2025-06-04 16:21:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4034
  Complete submission text file 0001950047-25-003817.txt   5604
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Subject) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36156 | Film No.: 251023378
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Leite John (Reporting) CIK: 0001991536 (see all company filings)

Type: 144